Skip to main content
. 2022 Sep 21;13:1005790. doi: 10.3389/fimmu.2022.1005790

Table 1.

Characteristics of the recipient and donor in transplants with and without pre-transplant DSA.

Characteristics DSA (n = 411) No DSA (n = 1804) p value (DSA vs. No DSA)
Female gender (Recipient) 197 (48%) 609 (34%) <0.0001
Age at transplantation (mean value) 51.7 52.8 0.04
Female gender (Donor) 190 (46%) 934 (52%) <0.0001
Age (Donor) (mean vlaue) 51.5 52.5
Previously transplanted 181 (44%) 221 (12%) <0.0001
Previous pregnancy 45 (23% in female) 130 (21% in female)
Previous blood transfusion 204 (50%);
62 (unknown)
479 (27%);
341 (unknown)
Immunosuppression <0.0001
FK-MPA-Pred 354 (86%) 1364 (77%)
CyA-MPA-Pred 44 (11%) 357 (20%)
CNI-based other 10 (3%) 19 (1%)
mTOR-containing 2 (1%) 48 (3%)
Other 1 (0%) 14 (0%)
Induction therapy <0.0001
ATG/Thymo+/- lvlg 275 (67%) 274 (16%)
Basiliximab 135 (33%) 1473 (81%)
None 1 (0%) 57 (3%)
Underlying renal disease <0.0001
Glomerulonephritis 92 (22%) 449 (25%)
ADPKD 75 (18%) 341 (19%)
Diabetic nephropathy 28 (7%) 161 (9%)
Vascular nephropathy 30 (7%) 222 (12%)
Interstitial nephropathy 10 (3%) 63 (4%)
Other 100 (24%) 403 (22%)
Not specified 58 (14%) 211 (12%)
Reflux/Pyelonephritis 18 (4%) 93 (5%)
Hereditary (not ADPKD) 11 (3%) 57 (3%)
Congenital 13 (3%) 42 (2%)
Unknown 76 (19%) 165 (9%)
HLA mismatch
A, % with 0/1/2 14/47/39 16/46/38 0.800
B, % with 0/1/2 6/41/53 9/40/51 0.180
DRB1, % with 0/1/2 10/56/34 18/53/29 0.002
Cold ischemia time (DD)/h
(mean value)
9.0 (6.9–12.1) 9.4 (7.3–12.3) 0.10
Donor type
No. of donation (DD/LD) 294/117 1118/686 <0.0001
Percentage. of donation
(DD/LD), %
71.5/28.5 62.0/38.0 <0.0001
Age donor (DD/LD)
(mean value)
50.7/53.5 51.9/53.6 0.362
Female gender of donor
(DD/LD), %
42.5/55.6 44.2/64.4 0.098

DD, Disease donation; LD, Living donation.